• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身炎症生物标志物可界定支气管扩张症患者的特定集群:一项大型队列研究

Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study.

作者信息

Wang Xuejie, Villa Carmen, Dobarganes Yadira, Olveira Casilda, Girón Rosa, García-Clemente Marta, Máiz Luis, Sibila Oriol, Golpe Rafael, Menéndez Rosario, Rodríguez-López Juan, Prados Concepción, Martinez-García Miguel Angel, Rodriguez Juan Luis, de la Rosa David, Duran Xavier, Garcia-Ojalvo Jordi, Barreiro Esther

机构信息

Lung Cancer and Muscle Research Group, Pulmonology Department, Hospital del Mar-IMIM, Parc de Salut Mar, PRBB, C/Dr. Aiguader, 88, 08003 Barcelona, Spain.

Department of Medicine, Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain.

出版信息

Biomedicines. 2022 Jan 21;10(2):225. doi: 10.3390/biomedicines10020225.

DOI:10.3390/biomedicines10020225
PMID:35203435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8869143/
Abstract

Differential phenotypic characteristics using data mining approaches were defined in a large cohort of patients from the Spanish Online Bronchiectasis Registry (RIBRON). Three differential phenotypic clusters (hierarchical clustering, scikit-learn library for Python, and agglomerative methods) according to systemic biomarkers: neutrophil, eosinophil, and lymphocyte counts, C reactive protein, and hemoglobin were obtained in a patient large-cohort ( = 1092). Clusters #1-3 were named as mild, moderate, and severe on the basis of disease severity scores. Patients in cluster #3 were significantly more severe (FEV, age, colonization, extension, dyspnea (FACED), exacerbation (EFACED), and bronchiectasis severity index (BSI) scores) than patients in clusters #1 and #2. Exacerbation and hospitalization numbers, Charlson index, and blood inflammatory markers were significantly greater in cluster #3 than in clusters #1 and #2. Chronic colonization by and COPD prevalence were higher in cluster # 3 than in cluster #1. Airflow limitation and diffusion capacity were reduced in cluster #3 compared to clusters #1 and #2. Multivariate ordinal logistic regression analysis further confirmed these results. Similar results were obtained after excluding COPD patients. Clustering analysis offers a powerful tool to better characterize patients with bronchiectasis. These results have clinical implications in the management of the complexity and heterogeneity of bronchiectasis patients.

摘要

利用数据挖掘方法,在来自西班牙在线支气管扩张症登记处(RIBRON)的一大群患者中定义了不同的表型特征。根据全身生物标志物:中性粒细胞、嗜酸性粒细胞和淋巴细胞计数、C反应蛋白和血红蛋白,在一个大的患者队列(n = 1092)中获得了三个不同的表型簇(层次聚类、Python的scikit-learn库和凝聚方法)。根据疾病严重程度评分,将第1-3簇分别命名为轻度、中度和重度。第3簇中的患者比第1和第2簇中的患者病情明显更严重(第一秒用力呼气容积、年龄、定植、病变范围、呼吸困难(FACED)、急性加重(EFACED)和支气管扩张严重指数(BSI)评分)。第3簇中的急性加重和住院次数、查尔森指数和血液炎症标志物明显高于第1和第2簇。第3簇中铜绿假单胞菌的慢性定植率和慢性阻塞性肺疾病(COPD)患病率高于第1簇。与第1和第2簇相比,第3簇中的气流受限和弥散能力降低。多变量有序逻辑回归分析进一步证实了这些结果。排除COPD患者后也获得了类似的结果。聚类分析为更好地表征支气管扩张症患者提供了一个强大的工具。这些结果对支气管扩张症患者复杂性和异质性的管理具有临床意义。

相似文献

1
Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study.全身炎症生物标志物可界定支气管扩张症患者的特定集群:一项大型队列研究
Biomedicines. 2022 Jan 21;10(2):225. doi: 10.3390/biomedicines10020225.
2
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity.非囊性纤维化支气管扩张症患者的表型聚类:嗜酸性粒细胞在疾病严重程度中的作用。
Int J Environ Res Public Health. 2021 Aug 10;18(16):8431. doi: 10.3390/ijerph18168431.
3
Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes.血液中性粒细胞计数可界定支气管扩张症患者的特定集群:对不同临床表型的一种提示
Biomedicines. 2022 Apr 30;10(5):1044. doi: 10.3390/biomedicines10051044.
4
The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis.用于评估支气管扩张严重程度的支气管扩张严重程度指数和FACED评分。
Pulmonology. 2018 May/June;24(3):149-154. doi: 10.1016/j.rppnen.2017.08.009. Epub 2018 Jan 3.
5
Profile of Clinical and Analytical Parameters in Bronchiectasis Patients during the COVID-19 Pandemic: A One-Year Follow-Up Pilot Study.新冠疫情期间支气管扩张症患者的临床与分析参数概况:一项为期一年的随访试点研究
J Clin Med. 2022 Mar 21;11(6):1727. doi: 10.3390/jcm11061727.
6
Impact of Chronic Bronchial Infection by on Bronchiectasis.[病原体名称]慢性支气管感染对支气管扩张的影响。 (注:原文中“by”后面缺少具体病原体名称)
J Clin Med. 2022 Jul 7;11(14):3960. doi: 10.3390/jcm11143960.
7
Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index.非囊性纤维化支气管扩张严重程度的评估:FACED评分与支气管扩张严重程度指数的比较
Open Respir Med J. 2015 Mar 31;9:46-51. doi: 10.2174/1874306401509010046. eCollection 2015.
8
Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.评估吸入抗生素对非囊性纤维化支气管扩张症成人的影响——来自最近临床试验的经验。
Expert Rev Respir Med. 2018 Sep;12(9):769-782. doi: 10.1080/17476348.2018.1503540. Epub 2018 Aug 3.
9
Baseline neutrophil-to-lymphocyte ratio as a predictor of response to hospitalized bronchiectasis exacerbation risks.基线中性粒细胞与淋巴细胞比值作为住院支气管扩张症加重风险反应的预测指标。
Eur Clin Respir J. 2024 Jun 27;11(1):2372901. doi: 10.1080/20018525.2024.2372901. eCollection 2024.
10
The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.非囊性纤维化支气管扩张症的多面性。一种聚类分析方法。
Ann Am Thorac Soc. 2016 Sep;13(9):1468-75. doi: 10.1513/AnnalsATS.201510-678OC.

引用本文的文献

1
Phenotypes and endotypes in bronchiectasis: a narrative review of progress toward precision medicine.支气管扩张症的表型和内型:精准医学进展的叙述性综述
J Thorac Dis. 2025 Apr 30;17(4):2640-2654. doi: 10.21037/jtd-2024-1945. Epub 2025 Apr 28.
2
Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes.血液中性粒细胞计数可界定支气管扩张症患者的特定集群:对不同临床表型的一种提示
Biomedicines. 2022 Apr 30;10(5):1044. doi: 10.3390/biomedicines10051044.
3
Chronic Obstructive Pulmonary Disease: The Present and Future.

本文引用的文献

1
Bronchiectasis and Eosinophils.支气管扩张症与嗜酸性粒细胞
Arch Bronconeumol. 2021 Nov;57(11):671-672. doi: 10.1016/j.arbr.2021.08.001.
2
Do Redox Balance and Inflammatory Events Take Place in Mild Bronchiectasis? A Hint to Clinical Implications.氧化还原平衡和炎症事件是否在轻度支气管扩张症中发生?对临床意义的提示。
J Clin Med. 2021 Sep 30;10(19):4534. doi: 10.3390/jcm10194534.
3
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity.非囊性纤维化支气管扩张症患者的表型聚类:嗜酸性粒细胞在疾病严重程度中的作用。
慢性阻塞性肺疾病:现状与未来
Biomedicines. 2022 Feb 20;10(2):499. doi: 10.3390/biomedicines10020499.
Int J Environ Res Public Health. 2021 Aug 10;18(16):8431. doi: 10.3390/ijerph18168431.
4
Differences in Nutritional Status and Inflammatory Biomarkers between Female and Male Patients with Bronchiectasis: A Large-Cohort Study.支气管扩张症女性与男性患者营养状况及炎症生物标志物的差异:一项大型队列研究
Biomedicines. 2021 Jul 28;9(8):905. doi: 10.3390/biomedicines9080905.
5
Systemic Inflammation and Oxidative Stress in Adults with Bronchiectasis: Association with Clinical and Functional Features.支气管扩张症成人的系统性炎症和氧化应激:与临床和功能特征的关联。
Clinics (Sao Paulo). 2021 Apr 16;76:e2474. doi: 10.6061/clinics/2021/e2474. eCollection 2021.
6
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile.基于气道免疫特征的支气管扩张症患者聚类分析。
Chest. 2021 May;159(5):1758-1767. doi: 10.1016/j.chest.2020.11.011. Epub 2020 Nov 18.
7
Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis.FACED 评分和支气管扩张严重指数在支气管扩张症中的预后表现:系统评价和荟萃分析。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20194514.
8
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials.吸入性糖皮质激素在降低合并血液嗜酸性粒细胞增多的支气管扩张症患者急性加重发作中的作用:两项随机临床试验的事后汇总分析
Respir Med. 2020 Oct;172:106127. doi: 10.1016/j.rmed.2020.106127. Epub 2020 Aug 25.
9
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of .支气管扩张症急性加重期及缓解期的全身炎症:……的影响
J Clin Med. 2020 Aug 13;9(8):2631. doi: 10.3390/jcm9082631.
10
Repeteability of Circulating Eosinophil Measures and Inhaled Corticosteroids Effect in Bronchiectasis. A Post Hoc Analysis of a Randomized Clinical Trial.支气管扩张症中循环嗜酸性粒细胞指标的可重复性及吸入性糖皮质激素的效果。一项随机临床试验的事后分析
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):681-683. doi: 10.1016/j.arbres.2020.06.005. Epub 2020 Jul 11.